The FDA recently issued a drug safety communication concerning the anti-nausea drug Anzemet. Anzemet has been linked to an increased risk of a potentially fatal abnormal heart rhythm, known as torsade de pointes. Anzemet poses a particular risk to patients with underlying heart conditions or heart rate or rhythm problems, such as those with… Continue Reading